This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A Prospective Study

Agustín Alomar, MD; José M. Giménez-Camarasa, MD; José M. de Moragas, MD

Arch Dermatol. 1978;114(9):1316-1319.

Abstract
• Levamisole hydrochloride, a nonspecific immunostimulant, was given to 30 children with atopic dermatitis (AD) in a double-blind manner during an eightmonth period. Clinical course findings, including intradermal reactions to tuberculin, candidin, and streptokinase-streptodornase; sensitization to dinitrochlorobenzene; peripheral blood T- and Blymphocytes; in vitro lymphocyte transformation with phytohemagglutinin; and serum levels of IgM, IgG, IgA, and IgE, were noted every two months. Fifteen children completed the study. Neither the clinical course nor the immunologic values showed substantial differences between the levamisole-treated and the placebo group. Our experience with levamisole in AD is disappointing.

(Arch Dermatol 114:1316-1319, 1978)

Author Affiliations
From the Department of Dermatology, Hospital de San Pablo, Autonomous University of Barcelona, Spain.

Footnotes
Accepted for publication April 7, 1978.

Reprint requests to Hospital de San Pablo, Av San Antonio M Claret 167, Barcelona-25, Spain.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?